Skip to main content

MoneyWorks4Me

The revenue declined to Rs. 126.81 millions for the quarter ended December 2024 as compared to Rs. 130.20 millions during the corresponding quarter last year.The company has announced a 49.70% increase in its profits to Rs . 10.09  millions for the  quarter ended December 2024 compared to Rs. 6.74 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 11.58 millions from 9.28 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 126.81 130.20 -2.60 378.71 357.67 5.88 479.75 467.83 2.55
Other Income 0.67 0.80 -16.25 2.21 2.40 -7.92 3.21 3.55 -9.58
PBIDT 11.58 9.28 24.78 30.52 5.02 507.97 15.89 -18.08 -187.89
Interest 0.84 1.63 -48.47 3.46 5.28 -34.47 6.76 7.21 -6.24
PBDT 10.74 7.65 40.39 27.06 -0.26 -10507.69 9.13 -25.29 -136.10
Depreciation 0.95 0.91 4.40 2.81 2.73 2.93 3.68 3.65 0.82
PBT 9.79 6.74 45.25 24.25 -2.99 -911.04 5.45 -28.94 -118.83
TAX -0.30 0.00 0.00 0.10 0.00 0.00 3.01 -12.22 -124.63
Deferred Tax -0.30 0.00 0.00 0.10 0.00 0.00 3.01 -12.22 -124.63
PAT 10.09 6.74 49.70 24.15 -2.99 -907.69 2.44 -16.72 -114.59
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) 9.13 7.13 28.12 8.06 1.40 474.20 3.31 -3.86 -185.70
Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..